Aceneuramic Acid Extended-Release (Ace-ER) Tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aceneuramic Acid Extended-Release (Ace-ER) Tablets, covering 2019-02-19 to 2019-02-19. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Aceneuramic Acid Extended-Release (Ace-ER) Tablets in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM) [Phase 3]